We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Blogs for April 2010

A Shocking Truth: GABA Antibodies Developing New Therapies for Clinical Depression

Thursday, April 29, 2010 - 04:15

Supplying antibodies for neuroscience research forms an important part of our work here at Novus Biologicals. Our antibody database is represented by more than 5,600 neuroscience products covering conditions ranging from sensory systems to neurodegeneration.

GABA (gamma-aminobutyric acid) plays a central role in neural research, as it is the major inhibitory neurotransmitter in the mammalian central nervous system (CNS). Disruption of GABA and its receptors have been expressed in a range of mental health conditions. A major study by Dr. Andrea Levinson, et. al. has suggested an important role in major depressive illness.

Easy Antibody Labeling, Regardless of Buffer or Concentration!

Wednesday, April 28, 2010 - 10:00

Novus Biologicals is excited to announce the release of a new line of Antibody Purification Kits, for use with our popular Lightning Link Antibody Labeling Kits. These new kits allow researchers to label any antibody, regardless of the buffer or concentration, using the quick and easy Lightning Link method. Antibodies are sometimes only available at low concentrations and often contain low molecular weight substances that interfere in labeling reactions with enzymes, biotin, streptavidin and fluorophores. The Antibody Concentration and Clean Up Kits allow for quick and easy concentration of antibodies or proteins. The Kit can also be used to reduce the concentration of many unwanted additives often...

Using Hypoxia Antibodies on Stem Cell Cultures

Tuesday, April 27, 2010 - 04:11

Stem cell marker antibodies are used to identify and isolate stem cells in vitro. Whereas adult stem cells can only differentiate into one cell type, embryonic stem cells (ESCs) have the unique ability to differentiate into a large variety. Stem cells can be genetically manipulated into specific cell lines, and researchers have recently developed a promising new method of producing ESC-like cell lines from adult stem cells. We at Novus Biologicals have a large antibody database specific to adult and embryonic stem cell research.

Stem cells are found in both healthy and diseased tissue. Cancer stem cells (CSCs) are expressed in both solid tumors and leukaemias, and are of particular interest as they are resistant to many therapies, and are thought to drive metastatic spread of cancer cells. Hypoxia is...

Routine WT1 Antibody Screen Uncovers an Exciting New Cancer-Cleaning Enzyme

Friday, April 23, 2010 - 04:07

Enzyme antibodies are widely used in both apoptosis and cancer studies, as disruption of the proteins regulating apoptosis is known to lead to formation of tumor cells in certain cancers. We at Novus Biologicals are continually growing our enzyme antibody database offerings.

Recently, a seemingly basic antibody study into the mechanism of action of WT1 (the Wilms tumour oncogene) revealed that the protease HtrA2 may have a hitherto unknown role as a 'cell cleaning' enzyme, able to eradicate WT1, thus preventing development of cancer. The Wilms tumor is an embryonic cancer identified by mutation of WT1, a transcription protein that normally acts as a tumor suppressor during kidney development. WT1 has...

Antibody Research into Rare Tumours could Lead to Cutting-Edge Cancer Treatments

Thursday, April 22, 2010 - 03:59

We at Novus Biologicals have a vast number of products in our antibody catalogue, targeted at cancer research. They cover areas as diverse as apoptosis and cell signalling pathways, and antibodies include those derived from a number of tumour cell lines.

Now, it looks as if our cancer antibody database is set to expand once more. Scientists have recently uncovered exciting new facts on sarcomas - rare tumours affecting only a small minority of people, which are found in tissues throughout the body. Despite the rarity of sarcomas, the findings have enormous ramifications on the field of cancer therapy as a whole. They could pave the way for a whole catalogue of new treatments for the most common cancers affecting man.

Sarcomas are found in muscle, nerves, joint tissues, deep skin tissues and blood vessels. The proteins causing them undergo unique, well-...

Bestrophin Research Reveals Potential Target for Glaucoma Therapy

Wednesday, April 21, 2010 - 03:54

The Bestrophin 1 to 4 group of proteins are membrane-bound globulins, encoded by the BEST genes 1 to 4. We at Novus Biologicals have a range of products for Best research on our antibody database; mainly targeted to Best-1.

Bestrophin antibodies are routinely used in tagging studies for retinal epithelial cells, as well as ocular disease research; in particular, macular degeneration caused by mutations of Best-1. This protein, which is encoded by the BEST1 (also known as VMD2) gene, is found in the basolateral retinal membrane where it aids regulation of voltage-dependant (anion) Calcium channels. It plays an additional role in ocular development. Over 120 mutations of Best-1 have been recorded. They are responsible for a wide range of ocular disease phenotypes, the most publicised of which is Best vitelliform macular dystrophy.

...

Mutations in CHD7 Provide Link Between CHARGE syndrome and Cancer Cell Metastasis

Tuesday, April 20, 2010 - 03:41

Antibody studies into human CHARGE syndrome have shown mutated CHD7 plays a major role in its development. CHARGE originates in neural crest cells (NCCs) during early embryonic development. It leads to a number of birth defects including craniofacial, heart, brain, urogenital, hearing and growth defects. New research conducted by Wysocka et al, of the Stamford University School of Medicine, indicates a connection with tumour development in adults.

Chromatin is the tightly-packed form of DNA found within the cell nucleus. It is controlled by a number of chromatin remodeler proteins, one of which is CHD7. CHD7 acts on nuclear proteins to allow activation or deactivation of various genes.

NCCs are unusual in that they migrate freely during embryonic development, differentiating into a range of cells including neural, heart, cartilage and bone cells. Wysocka et al, of the Stamford University School of Medicine, recently conducted...

City Gym Helps Sheffield University in FTO Fat Gene Research

Monday, April 19, 2010 - 03:36

The recently discovered FTO (Fat mass and obesity orientated) gene is of great interest to antibody research groups, throwing clearer insight into the reasons why some people have difficulty losing weight, even when following a healthy lifestyle.

Studies into serotonin (5-HT) are equally important, and its importance has been realised in a number of antibody studies into causes of weight gain. 5-HT receptors are located in the hypothalamus, which is a primary expression site for FTO. A number of research groups are currently looking at the way these two proteins may interact.

Recently, more than 70 obese volunteers signed up to a Sheffield sports centre to take part in a genetic study being conducted by the city's Hallam University. The research, which started early in 2009 and is ongoing, looks at changes in participants' motivation, compared to the levels of serotonin that is naturally...

IDH1 Mutation Throws Door Open on AML Research

Friday, April 16, 2010 - 03:30

We at Novus Biologicals have a large antibody database for cancer research. However, AML, or acute myeloid leukaemia, is one of the cancers for which the number of antibodies is still fairly small, owing to limited knowledge of the genes involved.

An exciting new discovery looks set to change all that. Recently, Thompson et al of Abramson Cancer Centre, Pennsylvania University, discovered mutated IDH1, or isocitrate dehydrogenase 1, in stock AML cells. The biomarker was 2HG (2-hydroxyglutarate), a metabolite specific only to the mutated form of IDH1. The results indicated that mutated IDH1 could account for up to 50% of all AML cases where a gene had previously not been identified.

Amish Genetic Purity Shown to be Ideal for In Vitro Metabolic Research

Wednesday, April 14, 2010 - 03:25

Human derived antibodies are widely used in disease research. These tend to be associated with cancer cell lines, such as the MCF7 breast tumour line, for which we provide both antibodies and whole cell lysate. The cells that are generated are identical in every respect to the originals, meaning reproducible results can be obtained years after the original cell lines were harvested.

When it comes to in vivo studies, however, it is generally accepted that genetically similar results are only obtainable from genetically homogenous laboratory strains (Zucker rats, ob-ob mice etc.) The idea of a genetically homogenous human strain would seem to be unfeasible, but one does, in fact, exist, in the Old Order Amish people of North America.

The Amish are a pure-bred race who can trace their ancestry back to a small group of 18th century Europeans. Their mode of living has remained remarkably...

Newly Validated Antibodies for Immunocytochemistry

Tuesday, April 13, 2010 - 16:01

Immunocytochemistry (ICC) is a frequently used technique that allows researchers to determine if an antigen is expressed by specific cellular or sub-cellular compartments via the use of antibodies. Many research-grade antibodies are suitable for ICC analysis, however many are not or have not been tested.

Our antibody catalog includes over 1,800 antibodies that have been tested for use in ICC analysis. We at Novus Biologicals recently validated 25 of our antibodies for use in ICC. This ICC testing was conducted on either HeLa cell extracts or NTERA-2 cells. HeLa is an immortal, cervical cancer cell line that is frequently used in scientific research, and NTERA-2 is a human neural cell line that is commonly used as well.

One of our Endoplasmic Reticulum Marker antibodies, an...

Overview of Signal Transduction Antibodies

Monday, April 12, 2010 - 03:20

At Novus Biologicals, we have over 9,000 products on our transduction antibody database. Signal transducers are proteins that facilitate movement of signals, i.e. molecules that cause a reaction, from outside to inside the cell, where they cause changes to cellular function and activity in either the cytoplasm or the nucleus. Transduction pathways are usually activated by complex enzyme cascades, and new proteins are constantly being developed. Thus, our antibody catalogue is constantly being updated.

There are three classes of cell signalling proteins, differentiated according to the methods of transduction. The first group, steroid hormone transducers, diffuse across the cell membrane, binding to receptors within the cellular matrix. Upon binding to their ligands, these receptors are released from binding proteins, such as HSP90, via a conformational shift. A nuclear localisation sequence is...

Visit Novus Biologicals at the AACR 101st Annual Meeting

Tuesday, April 6, 2010 - 16:19

We are excited to announce that we will be exhibiting at the American Association for Cancer Research (AACR) 101st Annual Meeting. AACR brings researchers together from across the globe, and as an international antibody supplier, we at Novus Biologicals are enthusiastic about being part of it! This year's Annual Meeting will be held at the Walter E. Washington Convention Center in Washington, DC from April 17, 2010 through April 21, 2010.

Stop by the Novus Biologicals booth (booth #1437) at AACR to say hello, learn about the latest antibodies for cancer research, and to pick up one of each of our 13 research area-specific,...


Blog Topics


Archives